Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Protagonist Therapeutics Inc buy JPMorgan Chase & Co.

Protagonist Therapeutics Inc
Start price
€21.80
28.02.24 / 50%
Target price
€34.13
28.02.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 28.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time.
Performance without dividends (%)
Name 1w 1m
Protagonist Therapeutics Inc - -
iShares Core DAX® -0.992% -3.231%
iShares Nasdaq 100 -0.225% -3.339%
iShares Nikkei 225® -0.736% -7.859%
iShares S&P 500 -0.509% -2.979%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Protagonist Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 34.133
Change
Ends at 28.02.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat

JPMorgan Chase & Co. 
0
Report Share
28.02.24

Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc

buy
Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€21.80
25.09.23
€32.11
25.09.24
-
24.02.22

JPMorgan Chase & Co. 
25.09.23 50%